TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes
6/18/2014 8:49:26 AM
MALVERN, Pa., June 17, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) (the "Company") announced the pricing of its offering of $47 million in aggregate principal amount of its 8% Convertible Senior Notes due 2019 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").
Help employers find you! Check out all the jobs and post your resume.
comments powered by